Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-030116
Filing Date
2013-05-23
Accepted
2013-05-23 15:27:37
Documents
1
Period of Report
2013-05-17

Document Format Files

Seq Description Document Type Size
1 rrd380972.html 3  
1 rrd380972.xml 3 4599
  Complete submission text file 0001181431-13-030116.txt   5885
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
KOLLURI KRISHNA KITTU (Reporting) CIK: 0001270521 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 13868154